MedAvail Holdings, Inc. Common Stock
MDVL
MDVL was delisted on the 12th of February, 2024.
6 hedge funds and large institutions have $202K invested in MedAvail Holdings, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 0 closing their positions.
39% more capital invested
Capital invested by funds: $145K → $202K (+$57K)
20% more funds holding
Funds holding: 5 → 6 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$36.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2.54K |
| 2 |
Morgan Stanley
New York
|
-$1.7K |
MDVL Hedge Fund Activity: Q2 2018 in Review
6 of the 4,369 institutional investors tracked by Wall St. Rank reported a position in MedAvail Holdings, Inc. Common Stock (MDVL) for Q2 2018, worth a combined $202K — up 39% from $145K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MDVL positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $36.5K. The largest seller was UBS Group, cutting an estimated $2.54K.
- 6 institutional investors held MedAvail Holdings, Inc. Common Stock (MDVL) as of Q2 2018, up from 5 in Q1 2018.
- Funds reported $202K of MedAvail Holdings, Inc. Common Stock stock for Q2 2018, up 39% quarter-over-quarter.
- 1 fund opened new MedAvail Holdings, Inc. Common Stock positions in Q2 2018 and 0 closed out, a net change of +1 holder.
- The largest MedAvail Holdings, Inc. Common Stock buyer in Q2 2018 was Citadel Advisors, an estimated $36.5K added.
- The largest MedAvail Holdings, Inc. Common Stock seller in Q2 2018 was UBS Group, an estimated $2.54K sold.
Based on aggregated 13F filings for Q2 2018.